Notably, Brazilin significantly stimulates the STING pathway in NSCLC, triggering the expression of CXCL10, CXCL9, and CCL5, which could help overcome resistance to immunotherapy. This evidence concerns the gene CXCL9 and non-small cell lung carcinoma.